---
$id: https://graph.org.ai/products/commodity/51161542
$type: Product
source: UNSPSC
code: "51161542"
title: "Furafylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Furafylline

**UNSPSC Code**: 51161542
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C12H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2087G0XX3, chemically known as 3-furfuryl-1,8-dimethylxanthine but generally known as furafylline, which bears US NIH Compound Identifier 3433. European Medicines Agency schedules Furafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07829MIG. The term FURAFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). FURAFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule furafylline under HS 29395900 and SITC 54145. As of Q4 2014, FURAFYLLINE remains the US FDA Preferred Term for this commodity. Furafylline bears US NLM identifiers UMLS ID C0060848 and NCI Concept Code C65779. SMILES: CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C.

